BiomX Inc. dismissed Kesselman & Kesselman (PwC) as its independent registered public accounting firm effective July 1, 2026, and simultaneously engaged Barzily & Co. as its new auditor. The company's previous audit reports for fiscal years 2024 and 2025 included an explanatory paragraph regarding substantial doubt about its ability to continue as a going concern. BiomX Inc. is a biotechnology company focused on developing therapeutic solutions for infectious diseases.
More from Tessera Defense & Homeland Security Inc.
